Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension.

ABSTRACT:

Background

Hypertension is considered an important risk factor for the coronavirus disease 2019 (COVID-19). The commonly anti-hypertensive drugs are the renin-angiotensin-aldosterone system (RAAS) inhibitors, calcium channel blockers (CCBs), and beta-blockers. The association between commonly used anti-hypertensive medications and the clinical outcome of COVID-19 patients with hypertension has not been well studied.

Methods

We conducted a retrospective cohort study that included all patients admitted with COVID-19 to Huo Shen Shan Hospital and Guanggu District of the Maternal and Child Health Hospital of Hubei Province, Wuhan, China. Clinical and laboratory characteristics were extracted from electronic medical records. Hypertension and anti-hypertensive treatment were confi

SUBMITTER: Peng C 

PROVIDER: S-EPMC8280095 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature